Skip to main content
Figure 5 | BMC Pharmacology

Figure 5

From: Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779

Figure 5

Early rapamycin treatment compared to late rapamycin treatment in nude mice bearing Tsc2-/- tumors. a) Average tumor growth over time for the early rapamycin-treated and late rapamycin-treated cohorts only. b) Enlargement of the boxed portion of part a) illustrating the difference in growth pattern between the two treatment cohorts in the first 20 days of treatment. c) Survival curve for the early rapamycin and late rapamycin-treated cohorts. d) Data shown in table format.

Back to article page

BMC Pharmacology

ISSN: 1471-2210